GT Biopharma
GTBP
GTBP
53 hedge funds and large institutions have $16.7M invested in GT Biopharma in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 23 increasing their positions, 6 reducing their positions, and 11 closing their positions.
Holders
53
Holders Change
–
Holders Change %
0%
% of All Funds
0.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
23
Reduced
6
Closed
11
Calls
$334K
Puts
$239K
Net Calls
+$95K
Net Calls Change
+$467K
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$3.68M |
| 2 |
2
Renaissance Technologies
New York
|
$935K |
| 3 |
3
Morgan Stanley
New York
|
$1.35M |
| 4 |
4
Two Sigma Advisers
New York
|
$366K |
| 5 |
5
State Street
Boston,
Massachusetts
|
$1.6M |
